Literature DB >> 8837233

Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups.

S Benjelloun1, B Bahbouhi, S Sekkat, A Bennani, N Hda, A Benslimane.   

Abstract

Hepatitis C virus (HCV) seroprevalence and transmission routes were investigated in several groups of the Moroccan population. This study showed a low HCV seroprevalence in the Moroccan general population. However, haemodialysis patients and haemophiliacs were at higher risk of having HCV infection, since the prevalences were, respectively, 35.1 and 42.4% in comparison with the blood donors' prevalence (1.1%). These results indicated that parenteral exposure is the transmission pathway of HCV. To investigate the possibility of vertical HCV transmission, a cohort of healthy, unselected pregnant women were included in the study. A prevalence of 1% was found among them. Seven newborns were anti-HCV-positive, although, when RT-PCR was used to search for HCV RNA in their sera, none of them was viraemic. These data indicated that anti-HCV antibodies were passively acquired in these cases. We concluded that vertical transmission is absent when mothers are at low risk of contracting other parenterally or sexually transmitted diseases. Three percent of a group of patients of a centre for sexually transmitted diseases were repeatedly anti-HCV-positive, suggesting the possible sexual transmission of HCV. When screening 116 sera of anti-HIV-positive subjects, 19.8% were anti-HCV-positive. Furthermore, 17.9% of the sixty-seven patients who were proven to have sexually contracted HIV were also anti-HCV-positive. These data might reflect a likely cotransmission of these two viruses, hence suggesting HIV is a cofacter for HCV sexual transmission, as previously reported.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837233     DOI: 10.1016/0923-2516(96)89656-7

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  10 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

3.  Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.

Authors:  Seyed Moayed Alavian; Seyed Hossein Aalaei-Andabili
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

Review 4.  The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.

Authors:  Fatima A Fadlalla; Yousra A Mohamoud; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

5.  The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Authors:  Roxana-Delia Trimbitas; Fatima Zahra Serghini; Fatiha Lazaar; Warda Baha; Abderrahim Foullous; Mohammed Essalhi; Abdelouahed El Malki; Abdelkrim Meziane Bellefquih; Abdelouaheb Bennani
Journal:  Virol J       Date:  2014-03-06       Impact factor: 4.099

6.  Prevalence of hepatitis B and C in blood transfusion center, Oujda Morocco (2013-2015).

Authors:  Samira Boubker; Nassiba Zerrouki; Zaina Sidqi; Maria Moussi; Amine El Mekkaoui; Wafaa Khannoussi; Ghizlane Kharrasse; Zahi Ismaili
Journal:  Pan Afr Med J       Date:  2019-07-03

7.  Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.

Authors:  Sayeh Ezzikouri; Rhimou Alaoui; Khadija Rebbani; Ikram Brahim; Fatima-Zohra Fakhir; Salwa Nadir; Helmut Diepolder; Salim I Khakoo; Mark Thursz; Soumaya Benjelloun
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 8.  A review of the infection-associated cancers in North African countries.

Authors:  Wafaa Mohamed Hussein; Wagida A Anwar; Mohammed Attaleb; Loubna Mazini; Asta Försti; Roxana-Delia Trimbitas; Meriem Khyatti
Journal:  Infect Agent Cancer       Date:  2016-08-10       Impact factor: 2.965

Review 9.  Hepatitis C Virus in North Africa: An Emerging Threat.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2016-08-16

Review 10.  Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.

Authors:  M Harfouche; H Chemaitelly; S Mahmud; K Chaabna; S P Kouyoumjian; Z Al Kanaani; L J Abu-Raddad
Journal:  Epidemiol Infect       Date:  2017-10-09       Impact factor: 4.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.